Markers of insulin resistance in Polycystic ovary syndrome women: An update

被引:49
作者
Amisi, Chantal Anifa [1 ]
机构
[1] Univ Campus Biomed Rome, Endocrinol & Diabet Unit, Dept Med, Via Alvaro del Portillo 21, I-00128 Rome, Italy
关键词
Markers; Insulin resistance; Polycystic ovary syndrome; Emerging markers; Impaired glucose tolerance; HOMEOSTASIS MODEL ASSESSMENT; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; GLUCOSE-TOLERANCE TEST; BODY-FAT DISTRIBUTION; BETA-CELL FUNCTION; SERUM-LIPOPROTEIN RATIOS; NECROSIS-FACTOR-ALPHA; TO-HEIGHT RATIO;
D O I
10.4239/wjd.v13.i3.129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 5%-10% of women of reproductive age. The importance of this syndrome lies in the magnitude of associated comorbidities: infertility, metabolic dysfunction, cardiovascular disease (CVD), plus psychological and oncological complications. Insulin resistance (IR) is a prominent feature of PCOS with a prevalence of 35%-80%. Without adequate management, IR with compensatory hyperinsulinemia contributes directly to reproductive dysfunction in women with PCOS. Furthermore, epidemiological data shows compelling evidence that PCOS is associated with an increased risk of impaired glucose tolerance, gestational diabetes mellitus and type 2 diabetes. In addition, metabolic dysfunction leads to a risk for CVD that increases with aging in women with PCOS. Indeed, the severity of IR in women with PCOS is associated with the amount of abdominal obesity, even in lean women with PCOS. Given these drastic implications, it is important to diagnose and treat insulin resistance as early as possible. Many markers have been proposed. However, quantitative assessment of IR in clinical practice remains a major challenge. The gold standard method for assessing insulin sensitivity is the hyperinsulinemic euglycemic glucose clamp. However, it is not used routinely because of the complexity of its procedure. Consequently, there has been an urgent need for surrogate markers of IR that are more applicable in large population-based epidemiological investigations. Despite this, many of them are either difficult to apply in routine clinical practice or useless for women with PCOS. Considering this difficulty, there is still a need for an accurate marker for easy, early detection and assessment of IR in women with PCOS. This review highlights markers of IR already used in women with PCOS, including new markers recently reported in literature, and it establishes a new classification for these markers.
引用
收藏
页码:129 / 149
页数:21
相关论文
共 242 条
  • [1] The Association Between Serum Ferritin Concentration and Visceral Adiposity Estimated by Whole-Body DXA Scan in Women With Polycystic Ovary Syndrome
    Adamska, Agnieszka
    Lebkowska, Agnieszka
    Krentowska, Anna
    Adamski, Marcin
    Kowalska, Irina
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 10
  • [2] Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome
    Adeniji, Adeola A.
    Essah, Paulina A.
    Nestler, John E.
    Cheang, Kai I.
    [J]. JOURNAL OF WOMENS HEALTH, 2016, 25 (06) : 638 - 645
  • [3] The metabolic syndrome - a new worldwide definition
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. LANCET, 2005, 366 (9491) : 1059 - 1062
  • [4] Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome
    Altinkaya, Sunduz Ozlem
    Nergiz, Sumeyra
    Kucuk, Mert
    Yuksel, Hasan
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 176 : 168 - 172
  • [5] Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance
    Amato, M. C.
    Vesco, R.
    Vigneri, E.
    Ciresi, A.
    Giordano, C.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2015, 38 (12) : 1319 - 1326
  • [6] Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI [10.2337/dc10-S011, 10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc12-s064, 10.2337/dc12-s011, 10.2337/dc14-S081, 10.2337/dc11-S062]
  • [7] Amini A, 2012, J PAK MED ASSOC, V62, pS34
  • [8] Biological insulin resistance in Congolese woman with polycystic ovary syndrome (PCOS)
    Amisi, C.
    Mputu, L.
    Mboloko, E.
    Bieleli, E.
    Pozzili, P.
    [J]. GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2013, 41 (12): : 707 - 710
  • [9] Wrist circumference: A new marker for insulin resistance in African women with polycystic ovary syndrome
    Amisi, Chantal Anifa
    Ciccozzi, Massimo
    Pozzilli, Paolo
    [J]. WORLD JOURNAL OF DIABETES, 2020, 11 (02) : 42 - 51
  • [10] [Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS3, DOI 10.2337/dc10-S003